NYRBI-03

The goal of this clinical trial is to learn if investigational drug NYR-BI03 is safe and tolerated when given as an intravenous infusion over 3 hours to healthy male and female volunteers.
The study will also show what if any medical problems participants have when taking drug NYR-BI03 and it will provide information on blood levels of the drug.
Researchers will compare drug NYR-BI03 to a placebo (a similar substance that contains no drug) to see if NYR-BI03 is safe and tolerated.
Participants will be administered drug NYR-BI03 or a placebo via intravenous infusion for 3 hours and be assessed by physical examination and laboratory tests.